UTI-Stat(R) (ProAntinox(R)) Effective for Recurrent Urinary Tract Infections
May 13 2010 - 8:30AM
Marketwired
Medical Nutrition USA, Inc. (NASDAQ: MDNU) today announced the
results of a clinical study showing that 91% of women with
recurrent urinary tract infections remained symptom-free while
taking the company's UTI-Stat® (ProAntinox®) supplement. The study,
which was published by Urology, the official journal of the
International Society of Urology, also found that UTI-Stat®
(ProAntinox®) significantly improved quality of life as measured by
the American Urologic Association Symptom Index.
The clinical trial was conducted by Dr. Aaron E. Katz, Professor
of Clinical Urology at Columbia University College of Physicians
and Surgeons and Director of the Center for Holistic Urology. Dr.
Katz and his team in three outpatient urology clinics administered
UTI-Stat® (ProAntinox®) daily for 12 weeks to 28 women from 34 to
59 years of age who had at least three UTIs in the previous six
months. Blood and urine samples were collected and analyzed for the
presence of infection, and safety monitoring was continuously
performed during the study period.
"Results showed that UTI-Stat® (ProAntinox®) had a good safety
profile and tolerability, and demonstrated effectiveness in
significantly reducing the anticipated incidence of recurrent UTI
and improving quality of life in females with a history of UTI,"
Dr. Katz said.
UTI-Stat® (ProAntinox®) is currently used in many nursing homes
and hospitals, where the incidence of urinary tract infections is
higher than in the general public. A 2008 study of 88 nursing home
residents with recurrent UTI showed that 92% remained symptom-free
while taking UTI-Stat (ProAntinox®).
"This new study by Dr. Katz shows that UTI-Stat® (ProAntinox®)
is equally as effective for younger women with recurrent UTI as it
has previously been shown to be for older, nursing home residents,"
said Arnold Gans, Chief Scientific Officer of Medical Nutrition
USA. "The absence of symptoms and the improved quality of life
shown in these studies are of huge benefit to those who are
susceptible to urinary tract infections."
ProAntinox® is also available over-the-counter as Cystex®
Cranberry.
The study can be found at:
http://www.goldjournal.net/article/S0090-4295(10)00183-4/abstract
About Medical Nutrition USA, Inc. Medical
Nutrition USA develops and distributes products for the
nutritionally at risk who are under medical supervision. Its
products are used primarily in long-term care facilities,
hospitals, dialysis clinics and bariatric clinics. The Company's
product lines include Pro-Stat®, Fiber-Stat®, UTI-Stat® and
Diff-Stat® as well as private label products. Additional
information is available at www.mdnu.com.
Forward-Looking Statements This news
release contains forward-looking statements that are subject to
certain risks and uncertainties. Although we believe that the
expectations reflected in any of our forward-looking statements are
reasonable, actual results could differ materially from those
projected or assumed. Risks and uncertainties that could cause or
contribute to such material difference include, but are not limited
to, general economic conditions, changes in customer demand,
changes in trends in the nursing home, renal care, health food and
bariatric surgery markets, changes in competitive pricing for
products, and the impact of our competitors' new product
introductions. Our future financial condition and results of
operations, as well as any forward-looking statements are subject
to change and inherent risk and uncertainties. Other important
factors that may cause actual results to differ materially from
those expressed in forward-looking statements are contained in the
Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year
ended January 31, 2010 as filed with the Securities and Exchange
Commission on April 16, 2010.
Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling
Vice President/CFO 800.221.0308 Email Contact Investor
Relations Adam Friedman 212.981.2529 x18 Email Contact
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Jan 2025 to Feb 2025
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Feb 2024 to Feb 2025